On this page
Factor X deficiency
This condition can lead to increased bleeding, ranging from mild to severe, and affects individuals from birth. It is an inherited disorder, meaning it is passed down through families.
Overview
Factor X deficiency is a rare genetic condition that affects the blood's ability to clot properly. It is categorised as a bleeding disorder, meaning individuals with this condition may experience prolonged or excessive bleeding [PMID:33671239]. The condition arises because there isn't enough functional Factor X protein in the blood or the protein doesn't work correctly. Factor X plays a crucial role in the coagulation cascade, which is the complex process that stops bleeding by forming a blood clot. Without sufficient working Factor X, this process is impaired, leading to the characteristic bleeding symptoms of the disorder.
This condition is present from birth, and its severity can vary significantly among affected individuals, even within the same family. It is an inherited condition, meaning it is passed down through families. The exact prevalence is estimated to be around 1 in 1,000,000 people globally, highlighting its rarity [PMID:17967389].
Symptoms & clinical features
The symptoms of Factor X deficiency can range from mild to severe and often depend on the level of functional Factor X in the blood. Mild forms might only become apparent after a significant injury or surgery, while severe forms can present with bleeding episodes early in life [PMID:19149747].
Common symptoms include easy bruising, nosebleeds that are difficult to stop, and prolonged bleeding after minor cuts, dental procedures, or surgery. Women with Factor X deficiency may experience heavy or prolonged menstrual bleeding (menorrhagia) and excessive bleeding during childbirth. In more severe cases, individuals may experience spontaneous bleeding into joints (haemarthrosis), muscles, or internal organs, which can be serious and require prompt medical attention. Bleeding into the brain (intracranial haemorrhage) is a rare but life-threatening complication.
Video: Genetics 101
Affected organs
Factor X deficiency primarily affects the blood and the body's clotting system, which has widespread implications. The most commonly affected areas are those prone to injury or where blood vessels are delicate. This includes the skin, leading to easy bruising and purpura (purple spots caused by bleeding under the skin). Mucous membranes, such as those lining the nose and mouth, are also frequently affected, resulting in nosebleeds and gum bleeding.
In more severe cases, internal bleeding can occur, potentially affecting joints (causing swelling and pain), muscles, and even vital organs like the brain or gastrointestinal tract. Persistent bleeding from surgical sites or wounds can also impact the healing process.
Risks & severity
The severity of Factor X deficiency is closely linked to the amount of functional Factor X present in the blood. Individuals with very low levels of Factor X typically experience more severe symptoms and may have spontaneous bleeding episodes from a young age. Those with higher, but still reduced, levels may have milder symptoms, often only experiencing bleeding after trauma, surgery, or during menstruation and childbirth.
Lifetime risks for individuals with Factor X deficiency include the potential for significant bleeding episodes that might require hospitalisation or transfusions. Bleeding into joints can lead to chronic joint damage if not managed effectively. Intracranial haemorrhage, although rare, represents a serious risk. Pregnant women with Factor X deficiency face an increased risk of bleeding complications during and after delivery.
Genetic causes
Factor X deficiency is caused by pathogenic variants in the F10 gene. This gene provides instructions for making coagulation factor X, a protein that plays a central role in the blood clotting process. Specifically, Factor X is involved in both the intrinsic and extrinsic pathways of coagulation, converting prothrombin into thrombin, which then converts fibrinogen into fibrin to form a stable blood clot.
When there are changes (variants) in the F10 gene, the body may produce a faulty Factor X protein, or not enough of it. This disruption means the coagulation cascade cannot proceed efficiently, leading to reduced clot formation and an increased tendency to bleed. Different variants in the F10 gene can lead to varying levels of functional Factor X, which explains the range of symptom severity observed in individuals with this condition.
- F10 coagulation factor X
Inheritance pattern
Factor X deficiency is inherited in an autosomal recessive pattern. This means that an individual must inherit two altered copies of the F10 gene - one from each parent - to develop the condition. If someone inherits only one altered copy and one normal copy, they are considered a 'carrier'. Carriers typically do not show symptoms of Factor X deficiency because their one working copy of the gene produces enough functional Factor X.
When two carriers have children, there is a 25% chance with each pregnancy that their child will inherit two altered copies of the F10 gene and be affected by Factor X deficiency. There is a 50% chance their child will be a carrier, and a 25% chance their child will inherit two normal copies of the gene and not be a carrier or affected.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
Diagnosis & testing
Diagnosing Factor X deficiency typically begins with a review of a person's bleeding history and a physical examination. Blood tests are then performed to assess blood clotting function. Initial screening tests may include a prothrombin time (PT) and activated partial thromboplastin time (aPTT), which are usually prolonged in Factor X deficiency. However, definitive diagnosis requires specific assays to measure the activity of Factor X in the blood [PMID:19149747].
Once a clotting factor deficiency is suspected, genetic testing of the F10 gene can confirm the diagnosis and identify the specific pathogenic variants responsible. This genetic testing is typically facilitated through Clinical Genetics services within the NHS. Genomic analysis for inherited bleeding disorders is supported within the NHS Genomic Medicine Service (GMS) pathways, often under R-codes such as R68 for inherited bleeding, platelet, and red cell disorders. A referral to a clinical geneticist or consultant haematologist is usually the starting point for accessing these diagnostic pathways.
Management & lifestyle
Management of Factor X deficiency focuses on preventing bleeding episodes and treating them promptly when they occur. Treatment options depending on the severity of the deficiency and the type of bleeding. For acute bleeding episodes or before surgical procedures, Factor X concentrate or fresh frozen plasma (FFP) may be administered to temporarily replace the missing factor [PMID:33671239]. Tranexamic acid, an antifibrinolytic agent, can also be used to help stabilise clots, particularly for mucous membrane bleeding.
Individuals with Factor X deficiency are typically managed by a multidisciplinary team, often led by a haematologist. Regular follow-up appointments are important for monitoring Factor X levels and overall health. Lifestyle advice often includes avoiding medications that can increase bleeding risk, such as aspirin and NSAIDs, and taking precautions to prevent injuries. Genetic counselling is also recommended for affected individuals and their families to understand the inheritance pattern and implications for family planning.
UK care pathway
In the UK, individuals suspected of having Factor X deficiency will typically be referred to a consultant haematologist, often through their GP or other specialist. These haematology services are usually based in specialist centres that have expertise in bleeding disorders. The diagnosis and management pathway often involves collaboration with NHS Genomic Medicine Service (GMS) by clinical geneticists.
Genetic testing for inherited bleeding disorders, such as Factor X deficiency, is available through the NHS GMS, often covered under specific R-codes for rare inherited bleeding disorders (e.g., R68). Patients can access genetic counselling through their clinical genetics service, which provides crucial information about the condition, its inheritance, and support for family planning.
Frequently asked questions
Can Factor X deficiency be cured?
Currently, there is no cure for Factor X deficiency, as it is a genetic condition. However, symptoms can be effectively managed through various treatments, including Factor X concentrates or fresh frozen plasma, which help to control and prevent bleeding episodes.
How serious is Factor X deficiency?
The severity varies greatly. Some individuals have mild symptoms with bleeding only after injury or surgery, while others with more severe forms can experience spontaneous and life-threatening bleeding into joints, muscles, or internal organs. The level of Factor X activity in the blood determines the severity.
Is Factor X deficiency common?
No, Factor X deficiency is considered a very rare condition, with an estimated prevalence of around 1 in 1,000,000 people. Its rarity means that healthcare professionals may not initially recognise the symptoms, potentially leading to delays in diagnosis.
What should I do if I have Factor X deficiency and need surgery?
It is crucial to inform your medical team about your Factor X deficiency well in advance of any surgery, including dental procedures. Your haematologist will work with the surgical team to ensure appropriate measures, such as Factor X replacement therapy, are taken to prevent excessive bleeding during and after the procedure.
Can Factor X deficiency affect pregnancy?
Yes, women with Factor X deficiency may experience heavy menstrual bleeding and face an increased risk of bleeding complications during and after childbirth. Careful management by a specialist haematologist and obstetrician is essential throughout pregnancy and delivery to ensure the safety of both mother and baby.
References
- Uprichard J, Perry DJ. Factor X deficiency. Blood reviews. 2002. PMID: 12127953
- Menegatti M, Peyvandi F. Factor X deficiency. Seminars in thrombosis and hemostasis. 2009. PMID: 19598069
- Glenner GG. Factor X deficiency and systemic amyloidosis. The New England journal of medicine. 1977. PMID: 405589
- Chigateri S, Jain A, Oli AK. Factor X deficiency and pregnancy. BMJ case reports. 2024. PMID: 38960427
- Wood JP. Paving the way to factor X deficiency therapies. Blood. 2024. PMID: 38990542
- Chitlur M, Amos LE, Reding MT. Characterization and management of patients with hereditary factor X deficiency: A case series. Transfusion. 2025. PMID: 41104456
- Perry DJ. Factor X and its deficiency states. Haemophilia : the official journal of the World Federation of Hemophilia. 1997. PMID: 27214799
- Menegatti M, Peyvandi F. Clinical, Laboratory Aspects and Management of Factor X Deficiency. Seminars in thrombosis and hemostasis. 2025. PMID: 39209291